All Stories

  1. Preclinical study of a DNA vaccine targeting SARS-CoV-2

    Article • Current Research in Translational Medicine, September 2022, Elsevier

    Shota Yoshida

  2. Prevention of vascular dementia via immunotherapeutic blockade of renin-angiotensin system in a rat model

    Article • Brain Research, December 2021, Elsevier

    Shota Yoshida

  3. Prevention of Acute Lung Injury by a Novel CD14-Inhibitory Receptor Activator of the NF-κB Ligand Peptide in Mice

    Article • ImmunoHorizons, June 2021, The American Association of Immunologists

    Shota Yoshida

  4. Development of anti-thrombotic vaccine against human S100A9 in rhesus monkey

    Article • Scientific Reports, June 2021, Springer Science + Business Media

    Shota Yoshida

  5. CD153 VACCINE IS A NOVEL SENOTHERAPEUTIC OPTION FOR REMOVING SENESCENCE-ASSOCIATED T CELLS

    Article • Journal of Hypertension, April 2021, Wolters Kluwer Health

    Shota Yoshida

  6. SARS-CoV-2-induced humoral immunity through B cell epitope analysis in COVID-19 infected individuals

    Article • Scientific Reports, March 2021, Springer Science + Business Media

    Shota Yoshida

  7. Preclinical study of DNA vaccines targeting SARS-CoV-2

    Article • October 2020, Cold Spring Harbor Laboratory Press

    Shota Yoshida

  8. SARS-CoV-2-induced humoral immunity through B cell epitope analysis and neutralizing activity in COVID-19 infected individuals in Japan

    Article • July 2020, Cold Spring Harbor Laboratory Press

    Shota Yoshida

  9. The CD153 vaccine is a senotherapeutic option for preventing the accumulation of senescent T cells in mice

    Article • Nature Communications, May 2020, Springer Science + Business Media

    Shota Yoshida

  10. Development of an IL-17A DNA Vaccine to Treat Systemic Lupus Erythematosus in Mice

    Article • Vaccines, February 2020, MDPI AG

    Shota Yoshida

  11. Preventative effects of the partial RANKL peptide MHP1-AcN in a mouse model of imiquimod-induced psoriasis

    Article • Scientific Reports, October 2019, Springer Science + Business Media

    Shota Yoshida

  12. Development of a novel RANKL-based peptide, microglial healing peptide1-AcN (MHP1-AcN), for treatment of ischemic stroke

    Article • Scientific Reports, December 2018, Springer Science + Business Media

    Shota Yoshida

  13. Therapeutic Effects of Systemic Administration of the Novel RANKL-Modified Peptide, MHP1, for Ischemic Stroke in Mice

    Article • BioMed Research International, July 2018, Hindawi Publishing Corporation

    Shota Yoshida

  14. Development of vaccine for dyslipidemia targeted to a proprotein convertase subtilisin/kexin type 9 (PCSK9) epitope in mice

    Article • PLOS One, February 2018, PLOS

    Shota Yoshida

  15. Glial fibrillary acidic protein (GFAP) is a novel biomarker for the prediction of autoimmune diabetes

    Article • The FASEB Journal, May 2017, Federation of American Societies For Experimental Biology (FASEB)

    Shota Yoshida

  16. Evaluating the potential of the GFAP-KLH immune-tolerizing vaccine for type 1 diabetes in mice

    Article • FEBS Letters, December 2016, Wiley

    Shota Yoshida